Literature DB >> 22282020

Mast cells mediate Pseudomonas aeruginosa lipopolysaccharide-induced lung inflammation in rat.

B V Lê1, H Khorsi-Cauet, V Bach, J Gay-Quéheillard.   

Abstract

Activated mast cells have been demonstrated to play a pivotal role in Pseudomonas aeruginosa lung infections. However, there is no report about the involvement of mast cells in P. aeruginosa lipopolysaccharide (LPS)-induced lung inflammation. This study aimed at evaluating the role of mast cells in P. aeruginosa LPS-induced lung inflammation in rats. Mast cells stabilization was carried out by intraperitoneal injections of cromolyn. Lung inflammation was induced by the intratracheal instillation of P. aeruginosa LPS (5 μg/kg bw) and inflammatory status was evaluated 4 h post-LPS instillation. We found that activated mast cells could constitute a pivotal source of several inflammatory cytokines, including TNF-α, IL-1β, and IL-6. These cells might regulate polymorphonuclear neutrophil (PMN) recruitment and be implicated in the alteration of alveolar-capillary permeability via the release of TNF-α and IL-1β. We also detected that activated mast cells could be involved in the alteration of the expression of two epithelial tight junction proteins (claudin-1 and occludin) during the acute phase of inflammation. Our results suggest that activated mast cells might play a critical role in P. aeruginosa LPS-induced lung inflammation. Therefore, mast cell stabilization may be a potential novel approach for the prevention and treatment of P. aeruginosa-induced lung infections.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22282020     DOI: 10.1007/s10096-011-1530-5

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  37 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Three distinct anti-allergic drugs, amlexanox, cromolyn and tranilast, bind to S100A12 and S100A13 of the S100 protein family.

Authors:  T Shishibori; Y Oyama; O Matsushita; K Yamashita; H Furuichi; A Okabe; H Maeta; Y Hata; R Kobayashi
Journal:  Biochem J       Date:  1999-03-15       Impact factor: 3.857

3.  Mast cell-derived tumour necrosis factor-alpha mediates macrophage inflammatory protein-2-induced recruitment of neutrophils in mice.

Authors:  Yusheng Wang; Henrik Thorlacius
Journal:  Br J Pharmacol       Date:  2005-08       Impact factor: 8.739

4.  Virulence factors from Pseudomonas aeruginosa increase lung epithelial permeability.

Authors:  A O Azghani; E J Miller; B T Peterson
Journal:  Lung       Date:  2000       Impact factor: 2.584

5.  Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity.

Authors:  Volaluck Supajatura; Hiroko Ushio; Atsuhito Nakao; Shizuo Akira; Ko Okumura; Chisei Ra; Hideoki Ogawa
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

6.  Protein phosphatase 2A and protein kinase Calpha are physically associated and are involved in Pseudomonas aeruginosa-induced interleukin 6 production by mast cells.

Authors:  Robert T M Boudreau; Rafael Garduno; Tong-Jun Lin
Journal:  J Biol Chem       Date:  2001-11-12       Impact factor: 5.157

7.  Modulation of epithelial sodium channel activity by lipopolysaccharide in alveolar type II cells: involvement of purinergic signaling.

Authors:  Emilie Boncoeur; Valérie Tardif; Marie-Claude Tessier; Frédéric Morneau; Jacynthe Lavoie; Erik Gendreau-Berthiaume; Ryszard Grygorczyk; André Dagenais; Yves Berthiaume
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-12-11       Impact factor: 5.464

8.  Control of Pseudomonas aeruginosa in the lung requires the recognition of either lipopolysaccharide or flagellin.

Authors:  Reuben Ramphal; Viviane Balloy; Jeevan Jyot; Amrisha Verma; Mustapha Si-Tahar; Michel Chignard
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

Review 9.  Pseudomonas aeruginosa virulence and therapy: evolving translational strategies.

Authors:  Jeffrey L Veesenmeyer; Alan R Hauser; Thiago Lisboa; Jordi Rello
Journal:  Crit Care Med       Date:  2009-05       Impact factor: 7.598

10.  Compartmentalization of intraalveolar and systemic lipopolysaccharide-induced tumor necrosis factor and the pulmonary inflammatory response.

Authors:  S Nelson; G J Bagby; B G Bainton; L A Wilson; J J Thompson; W R Summer
Journal:  J Infect Dis       Date:  1989-02       Impact factor: 5.226

View more
  5 in total

1.  Mast cells play an important role in chlamydia pneumoniae lung infection by facilitating immune cell recruitment into the airway.

Authors:  Norika Chiba; Kenichi Shimada; Shuang Chen; Heather D Jones; Randa Alsabeh; Anatoly V Slepenkin; Ellena Peterson; Timothy R Crother; Moshe Arditi
Journal:  J Immunol       Date:  2015-03-09       Impact factor: 5.422

2.  Autophagy enhances bacterial clearance during P. aeruginosa lung infection.

Authors:  Robert D Junkins; Ann Shen; Kirill Rosen; Craig McCormick; Tong-Jun Lin
Journal:  PLoS One       Date:  2013-08-28       Impact factor: 3.240

3.  Zingerone suppresses liver inflammation induced by antibiotic mediated endotoxemia through down regulating hepatic mRNA expression of inflammatory markers in Pseudomonas aeruginosa peritonitis mouse model.

Authors:  Lokender Kumar; Sanjay Chhibber; Kusum Harjai
Journal:  PLoS One       Date:  2014-09-03       Impact factor: 3.240

Review 4.  Impact of Bacterial Toxins in the Lungs.

Authors:  Rudolf Lucas; Yalda Hadizamani; Joyce Gonzales; Boris Gorshkov; Thomas Bodmer; Yves Berthiaume; Ueli Moehrlen; Hartmut Lode; Hanno Huwer; Martina Hudel; Mobarak Abu Mraheil; Haroldo Alfredo Flores Toque; Trinad Chakraborty; Jürg Hamacher
Journal:  Toxins (Basel)       Date:  2020-04-02       Impact factor: 4.546

5.  Paclitaxel-induced lung injury and its amelioration by parecoxib sodium.

Authors:  Wen-jie Liu; Zhong-jian Zhong; Long-hui Cao; Hui-ting Li; Tian-hua Zhang; Wen-qian Lin
Journal:  Sci Rep       Date:  2015-08-10       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.